Atlanta, GA- 20 Sept 2018 - OncoLens™ has been selected from among hundreds of companies as a Venture Atlanta Startup Showcase company. OncoLens™ is a cloud- based SaaS (software as a service) platform that improves the quality of cancer care by streamlining multi-disciplinary case collaboration among providers and providing clinical decision support. This multi-disciplinary approach has shown increased positive outcomes for cancer patients. OncoLensTM automatically collects needed information in a platform which promotes collaboration, multi-disciplinary treatment planning, and clinical trial participation. Utilizing OncoLens™ services, clients have decreased their administrative time for treatment planning by up to 90% and allowed clients to run additional cases through this multi-disciplinary approach. The use of OncoLens™ has been proven to improve the quality and time to treatment for cancer patients.
OncoLens™ co-founder and CEO, Anju Mathew, is excited and honored to be selected from among a very large cohort of deserving companies. "Our service supports the multi-disciplinary team in planning the best course of treatment for patients. By having data such as clinical trials, targeted therapies and evidence-based guidelines applicable to the specific patient case, we support the improved quality of care. It is a great honor to be recognized for our work and market traction by the premier venture event in the South East."
Venture Atlanta Venture Atlanta is the Southeast's premier technology innovation and investor conference. The annual event will be held on October 16-17. Since its inception, Venture Atlanta has served as a launch pad for many of today's successful technology companies.